慧與科技(HPE.US)委任晶片工具商科磊(KLAC.US)主席加入董事會 緩和與維權投資者Elliott爭拗
《路透》報道,慧與科技(Hewlett Packard Enterprise)(HPE.US)委任晶片工具製造商科磊(KLAC.US)主席Robert Calderoni加入董事會,並擔任新成立的策略委員會,以暫停與維權投資者Elliott投資管理的爭拗。根據公司與Elliott的共識,Elliott亦可委任其一名高層加入董事會,為期最少一年。Elliott亦不會對董事會發起授權書挑戰。
惠普企業早前完成對Juniper Networks的140億美元收購,報道引述消息指,新加入董事將確保有關交易順利。
Elliott目前為惠普企業大股東之一,持有逾15億美元股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.